Catalent provides fill/finish services across a range of product formats from clinical to commercial scale.
From sites in the U.S. and Europe, Catalent provides drug product development and manufacturing services, leveraging proven expertise from pre-clinical to commercial launch and supply of small molecules, biologics, vaccines, and biosimilars. Catalent has extensive experience with drug product process development across a variety of liquid and lyophilized formulations into vials, syringes and cartridges. Our facilities and high-speed filling lines offer aseptic processing that is flexible, fast, and integrated with secondary packaging.
CPHI Barcelona 2023
Stop by the Catalent Stand for a Taste of Spain networking reception taking place on Wednesday, October 25, 2023 from 4:30PM-6:30PM.